Celltrion’s Omlyclo is interchangeable with Xolair to treat the same conditions: asthma, chronic rhinosinusitis, food allergy ...

only 8 mg syringes available from manufacturer Administered 10 mg (10 mg/mL) of morphine instead of 1 mg (1 mg/mL); patient required naloxone and was transferred to critical care Misfilled an ...

only 8 mg syringes available from manufacturer Administered 10 mg (10 mg/mL) of morphine instead of 1 mg (1 mg/mL); patient required naloxone and was transferred to critical care Misfilled an ...

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year ...

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

The PETITE study is evaluating two formulations of dolutegravir in newborn babies under 4 weeks of age – an oral film. In the ...

Delhi Police arrested an 18-year-old quack for administering incorrect injections to a man, leading to his death.

The FDA approved omalizumab-igec (Omlyclo) as the first biosimilar for omalizumab (Xolair) and the first for any respiratory ...

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...